| Year |
Citation |
Score |
| 2019 |
Posavi M, Diaz-Ortiz M, Liu B, Swanson CR, Skrinak RT, Hernandez-Con P, Amado DA, Fullard M, Rick J, Siderowf A, Weintraub D, McCluskey L, Trojanowski JQ, Dewey RB, Huang X, et al. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. Plos Medicine. 16: e1002931. PMID 31603904 DOI: 10.1371/Journal.Pmed.1002931 |
0.62 |
|
| 2016 |
Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Annals of Clinical and Translational Neurology. 3: 346-55. PMID 27231704 DOI: 10.1002/Acn3.299 |
0.685 |
|
| 2015 |
Swanson CR, Alcalay RN, Chen-Plotkin A. Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1975-6. PMID 26584479 DOI: 10.1002/mds.26447 |
0.586 |
|
| 2015 |
Swanson CR, Berlyand Y, Xie SX, Alcalay RN, Chahine LM, Chen-Plotkin AS. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1648-56. PMID 26207725 DOI: 10.1002/Mds.26290 |
0.657 |
|
| 2015 |
Swanson CR, Li K, Unger TL, Gallagher MD, Van Deerlin VM, Agarwal P, Leverenz J, Roberts J, Samii A, Gross RG, Hurtig H, Rick J, Weintraub D, Trojanowski JQ, Zabetian C, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 805-12. PMID 25227208 DOI: 10.1002/Mds.26022 |
0.731 |
|
| 2014 |
Emborg ME, Hurley SA, Joers V, Tromp do PM, Swanson CR, Ohshima-Hosoyama S, Bondarenko V, Cummisford K, Sonnemans M, Hermening S, Blits B, Alexander AL. Titer and product affect the distribution of gene expression after intraputaminal convection-enhanced delivery. Stereotactic and Functional Neurosurgery. 92: 182-94. PMID 24943657 DOI: 10.1159/000360584 |
0.708 |
|
| 2014 |
Swanson C, Emborg M. Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates. Neurological Research. 36: 634-46. PMID 24620964 DOI: 10.1179/1743132813Y.0000000305 |
0.569 |
|
| 2013 |
Swanson CR, Du E, Johnson DA, Johnson JA, Emborg ME. Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP. Ppar Research. 2013: 582809. PMID 24223584 DOI: 10.1155/2013/582809 |
0.656 |
|
| 2013 |
Emborg ME, Liu Y, Xi J, Zhang X, Yin Y, Lu J, Joers V, Swanson C, Holden JE, Zhang SC. Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Reports. 3: 646-50. PMID 23499447 DOI: 10.1016/J.Celrep.2013.02.016 |
0.693 |
|
| 2012 |
Ohshima-Hosoyama S, Simmons HA, Goecks N, Joers V, Swanson CR, Bondarenko V, Velotta R, Brunner K, Wood LD, Hruban RH, Emborg ME. A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys. Plos One. 7: e39036. PMID 22745701 DOI: 10.1371/Journal.Pone.0039036 |
0.743 |
|
| 2011 |
Swanson CR, Joers V, Bondarenko V, Brunner K, Simmons HA, Ziegler TE, Kemnitz JW, Johnson JA, Emborg ME. The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. Journal of Neuroinflammation. 8: 91. PMID 21819568 DOI: 10.1186/1742-2094-8-91 |
0.731 |
|
| 2009 |
Swanson CR, Sesso SL, Emborg ME. Can we prevent parkinson's disease? Frontiers in Bioscience (Landmark Edition). 14: 1642-60. PMID 19273153 DOI: 10.2741/3331 |
0.717 |
|
| Show low-probability matches. |